DOJ’s 100+ Campus Probes: UC Davis Accused of Admissions Race Discrimination

The legal community is parsing the DOJ’s latest salvo, which moves beyond the Supreme Court’s 2023 mandate into active enforcement that could reshape civil rights law. By accusing UC Davis of a systematic proxy for race—the ‘Davis Scale’—and calling it a ‘species of fraud,’ the government is laying groundwork for potential False Claims Act actions and signaling that diversity rationales will no longer shield institutions from Title VI or constitutional scrutiny. With 100 investigations underway, law firms advising universities must prepare for a wave of litigation and compliance reviews.

The U.S. Department of Justice has opened a high-stakes front in its campaign to enforce the Supreme Court’s 2023 ban on race-conscious admissions by accusing the University of California, Davis School of Medicine of systematically discriminating against white and Asian applicants. In a June 11, 2026 video statement and subsequent interviews, Assistant Attorney General for Civil Rights Harmeet Dhillon alleged that UC Davis Medical School created a “Davis Scale” that lowered the bar for Black, Hispanic, and other underrepresented minority applicants relative to their white and Asian peers by adjusting the impact of GPA and MCAT scores based on perceived disadvantage. The DOJ frames the practice as an intentional circumvention of Students for Fair Admissions v. Harvard, the landmark ruling that ended affirmative action in higher education, and a violation of federal antidiscrimination laws tied to the billions of dollars in federal funding that U.S. colleges and universities receive each year.

“

The immediate implications for UC Davis Medical School are severe.

The UC Davis probe is not an isolated case but part of a sweeping DOJ initiative that Dhillon described as “a major project.” She disclosed that the Civil Rights Division has launched approximately 100 investigations into higher education institutions, most of which remain pending, and that 30 of those probes focus specifically on medical schools for alleged DEI-related violations. Harvard and UCLA are also under scrutiny — Harvard for antisemitism and employment practices, UCLA for similar issues — and Dhillon warned that thousands of federally funded schools may have made false certifications of compliance with civil rights laws. This coordinated enforcement push marks a dramatic escalation in the post-Students for Fair Admissions legal landscape, transforming what had been a struggle over admissions policies into a broad federal civil rights campaign with potential financial and reputational consequences for academic institutions nationwide.

The immediate implications for UC Davis Medical School are severe. The DOJ’s public accusation signals that litigation or an enforcement action could follow, potentially jeopardizing the school’s access to federal grants, Medicare payments for affiliated teaching hospitals, and other Department of Education funds. Beyond the specific institution, the probe freezes the legitimacy of any admissions schema that attempts to engineer diversity through indirect proxies for race. The “Davis Scale” as described — ranking applicants by perceived disadvantage and recalculating quantitative metrics — suggests a systematic effort to build a parallel review system that may have been intended to survive judicial review but now faces attack as a de facto quota. Medical schools around the country that have adopted similar holistic review rubrics or “distance traveled” assessments will be watching closely, as the DOJ’s rationale could brand such tools as discriminatory.

For the broader landscape of medical education, the probe threatens to roll back years of diversity, equity, and inclusion initiatives. Medical schools have long argued that a diverse physician workforce improves health outcomes for underserved communities, and many have relied on holistic admissions precisely because traditional metrics like MCAT scores and GPAs correlate with socioeconomic factors. The DOJ’s position, however, asserts that the Constitution and federal law require colorblind admissions, and any deviation that disadvantages individual applicants on the basis of race is impermissible. This clash places medical educators in a bind: if they abandon diversity-conscious approaches, they risk exacerbating health disparities; if they persist, they face DOJ litigation and the loss of federal money.